血红素通过与GPIbα结合来调节血清性疾病中的血小板清除
Man Zhao1, Dongxin Peng1, Yuxuan Li1
1Field Blood Transfusion, Institute of Health Service and Transfusion Medicine, Beijing, China.
Platelets
|July 29, 2024
概括
血液溶解激活了血小板,但阻碍了巨细胞的清除. 血红蛋白的副产品血红素与糖蛋白Iba结合,减少血小板脱离和延长血小板的寿命在溶血性疾病.
科学领域:
- 血液学 血液学 血液学
- 血管生物学 血管生物学
- 免疫学 免疫学 免疫学
背景情况:
- 血液溶解,红细胞的分解,与各种疾病中的血栓形成和血管功能障碍有关.
- 血红蛋白降解产品,如血红素激活血小板 (PLT),但它们对血小板清除的影响还不清楚.
- 维持正常的血小板数量和功能对于血液静止和整体健康至关重要.
研究的目的:
- 为了研究血红素对血小板激活,清除和寿命的影响.
- 阐明糖蛋白Ibα (GPIbα) 在血小板血中介反应中的作用.
- 了解血液溶解条件下对血小板动态的影响.
主要方法:
- 在体外治疗血小板与半膜模拟溶血条件.
- 在小鼠体内研究,包括血小板输血和清除评估.
- 对血小板激活标记物的分析 (细胞内Ca2+,PS暴露,细胞骨变化).
- 研究血红素与GPIbα的结合及其对血小板脱离的作用 (RCA-I结合).
主要成果:
- 血红素治疗诱导了血小板激活,包括细胞内Ca2+的增加,PS暴露和细胞骨重组.
- 与未经治疗的血小板相比,用血红素治疗的血小板显示肝细胞巨细胞的清除减少.
- 血红素与GPIbα结合,促进血小板激活和聚合.
- 血红素降低了GPIbα脱氧化,通过减少RCA-I结合而表明,在体内延长了血小板存活时间.
结论:
- 血红素在血液溶解期间调节血小板行为的过程中起着重要作用.
- 血红素诱导的血小板激活和延长寿命是通过GPIbα结合和减少脱氧化调节的.
- 这些发现为血液溶解性疾病中的血小板清除机制提供了新的见解,并建议潜在的治疗点.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
13.8K
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
9.4K
相关概念视频
Formation of the Platelet Plug
5.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Introduction to Hemostasis
6.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.9K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781
